0001179022-15-000084.txt : 20150708
0001179022-15-000084.hdr.sgml : 20150708
20150708165829
ACCESSION NUMBER: 0001179022-15-000084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150312
FILED AS OF DATE: 20150708
DATE AS OF CHANGE: 20150708
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GALECTIN THERAPEUTICS INC
CENTRAL INDEX KEY: 0001133416
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043562325
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
BUSINESS PHONE: 678-620-3186
MAIL ADDRESS:
STREET 1: 4960 PEACHTREE INDUSTRIAL BOULEVARD
STREET 2: SUITE 240
CITY: NORCROSS
STATE: GA
ZIP: 30071
FORMER COMPANY:
FORMER CONFORMED NAME: PRO PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prelack Steven
CENTRAL INDEX KEY: 0001302315
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31791
FILM NUMBER: 15979716
MAIL ADDRESS:
STREET 1: 7 WHEELWRIGHT ROAD
CITY: MEDFIELD
STATE: MA
ZIP: 02052
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-03-12
0001133416
GALECTIN THERAPEUTICS INC
GALT
0001302315
Prelack Steven
C/O GALECTIN THERAPEUTICS INC.
4960 PEACHTREE INDUSTRIAL BLVD., STE 240
NORCROSS
GA
30071
1
0
0
0
Common Stock
2015-03-12
4
A
0
11112
0
A
14048
D
Common Stock
2015-04-08
4
A
0
2259
0
A
16307
D
Common Stock
2015-04-08
4
A
0
90882
0
A
107189
D
Stock Option (right to buy)
7.08
2015-04-08
4
D
0
6168
D
2021-06-28
Common Stock
6168
0
D
Stock Option (right to buy)
3.59
2015-04-08
4
D
0
16714
D
2023-03-28
Common Stock
16714
0
D
The option vested as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011.
The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 19,504 shares of restricted common stock, reported in Table 1 of this Form 4 as a part of the April 8, 2015 grant of 90,882 shares, as consideration for the cancellation of options granted on June 28, 2011 and March 28, 2013.
The option vested quarterly in eight equal installments beginning on May 12, 2013.
/s/ Jack W. Callicutt as Power of Attorney for Steven Prelack
2015-07-08